Collagen peptide with anti-aging effect and preparation method and application thereof
The novel collagen peptide Sa1, constructed using gene recombination technology, solves the safety and functional limitations of natural collagen, achieving antioxidant and anti-aging effects in skincare products and demonstrating significant skin improvement efficacy.
Patent Information
- Application Number
- CN202511524664.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-24
- Publication Date
- 2026-07-03
- Estimated Expiration
- 2045-10-24
AI Technical Summary
In existing technologies, natural collagen extracted from animals carries the risk of immunogenicity and viral contamination, while single-type recombinant collagen cannot mimic the synergistic effect of multiple collagens in the natural extracellular matrix, thus limiting its application effectiveness.
By using gene recombination technology, the effective active sequences of human type III and type XVII collagen are spliced and recombined to construct a novel collagen peptide Sa1, which has antioxidant properties. The purified peptide was obtained by expression in Pichia pastoris and can be applied to skin care products and other fields.
The novel collagen peptide Sa1 has good safety and significant antioxidant effects. It can promote the absorption of collagen in the skin, improve skin elasticity, delay skin aging, and has no cytotoxicity.